RBC Capital Upgrades PharMerica (PMC) to Outperform
Tweet
Share
E-mailGet Alerts PMC Hot Sheet
Price: $29.25 --0%
Rating Summary:
3 Buy, 7 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
3 Buy, 7 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
RBC Capital upgraded PharMerica (NYSE: PMC) from Sector Perform to Outperform, price target raised from $13 to $15.
For an analyst ratings summary and ratings history on PharMerica click here. For more ratings news on PharMerica click here.
Shares of PharMerica closed at $11.51 yesterday.
For an analyst ratings summary and ratings history on PharMerica click here. For more ratings news on PharMerica click here.
Shares of PharMerica closed at $11.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Upgrades Apollo Tyres (APTY:IN) to Buy
- China Resources Beer Holdings Co Ltd. (291:HK) (CRHKY) PT Lowered to HK$31 at Macquarie
- HSBC Downgrades Kakao Corp. (035720:KS) to Hold
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
